Rutoside trihydrate has the potential to inhibit pro-inflammatory genes transcription in human macrophages [10]. The dosage used for oral enzymes was rutoside trihydrate 100 mg, bromelain 90 mg, trypsin 48 mg, which is an acceptable dosage and was used as enteric coated tablets.